Friday’s jobs report and tumbling inflation expectations helped push the S&P 500 to a 2023 high, with the Nasdaq almost there, suggesting the market rally may be on the cusp of another leg higher. Arm Holdings blasted out of an IPO base as chip stocks heat up. Microsoft has held a buy point and a key level. Crispr Therapeutics won a historic FDA approval, but CRSP suffered a classic “sell the news” reversal.
